Creatine Therapy for Huntington's Disease

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

October 31, 2001

Study Completion Date

June 30, 2006

Conditions
Huntington's Disease
Interventions
DRUG

Creatine

Trial Locations (4)

10032

Karen Marder, M.D., New York

14642

Peter Como, Ph.D., Rochester

02129

Steven Hersch, M.D., Ph.D., Boston

Unknown

Andrew Feigin, M.D., Long Island City

All Listed Sponsors
lead

National Center for Complementary and Integrative Health (NCCIH)

NIH

NCT00026988 - Creatine Therapy for Huntington's Disease | Biotech Hunter | Biotech Hunter